Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial
Open Access
- 1 January 2014
- journal article
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 6 (3), 208-215
- https://doi.org/10.4168/aair.2014.6.3.208
Abstract
To evaluate a therapeutic efficacy of probiotics mixture (probiotics) in the treatment of children with mild-to-moderate atopic dermatitis (AD). Randomized, double-blind, placebo-controlled, parallel trial with a washout period of 2 weeks and an intervention period for 6 weeks, conducted from November 2010 to October 2011. One hundred children with mild to moderate AD (2-9 years old) were randomly allocated to the probiotics (Lactobacilluss casei, Lactobacillus rhamnosus, Lactobacillus plantarum, and Bifidobacterium lactis) or placebo groups. The assessment of efficacy was based on the change in eczema area severity index (EASI), visual analogue scale for pruritus (VASP), fecal cell counts of each strains (log10[cell counts/g stool]), and serum cytokine levels (Interleukin-4 [IL-4]; IL-10; Tumor necrosis factor alpha, [TNF-α]) in weeks 0 and 6. Demographics and baseline characteristics at the week 0 were not significantly different between the 2 groups. The significant increments in fecal-cell counts were observed in the probiotcs group at week 6 (P=0.00), while the cytokine levels between the 2 groups were not significantly different in week 6 (IL-4, P=0.50; IL-10, P=0.58; TNF-α, P=0.82). The probiotics significantly improved clinical severity after 6 weeks' intervention of probiotics; however, the placebo group also showed significant improvement (EASI; P=0.00, VASP; P=0.00). Our findings showed that probiotics successfully colonized in the intestine after 6 weeks' intervention; nevertheless, we could not find an additional therapeutic or immunomodulatory effects on the treatment of AD. Further long-term studies will be necessary to clarify the therapeutic efficacy of probiotics.Keywords
Funding Information
- CellBiotec
This publication has 26 references indexed in Scilit:
- Unbalance of intestinal microbiota in atopic childrenBMC Microbiology, 2012
- Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC / Nga miceJournal of Applied Microbiology, 2011
- Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at riskClinical and Experimental Allergy, 2010
- Effect of Lactobacillus sakei supplementation in children with atopic eczema–dermatitis syndromeAnnals of Allergy, Asthma & Immunology, 2010
- Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidencePediatric Allergy and Immunology, 2010
- Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Prevention and Management of Allergic Diseases by Probiotics1–3Journal of Nutrition, 2010
- Mechanisms of probiotic actions – A reviewInternational Journal of Medical Microbiology, 2010
- Phenotypic and genetic heterogeneity of lactic acid bacteria isolated from “Alheira”, a traditional fermented sausage produced in PortugalMeat Science, 2009
- Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjectsImmunobiology, 2008
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993